RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression

Keyphrases

• Human Telomerase Reverse Transcriptase (hTERT) 100%
• Cancer Progression 100%
• Epithelial Ovarian Cancer 100%
• Cancer Growth 100%
• Rif1 100%
• Knockdown 26%
• Human Ovarian Cancer Cell 26%
• Cancer Cell Growth 13%
• Overexpression 13%
• Tumorigenesis 13%
• Ovarian Cancer Patients 13%
• Xenograft Model 13%
• Luciferase Reporter Assay 13%
• Ovarian Tissue 13%
• Human Telomerase Reverse Transcriptase Promoter 13%
• Promoter Activity 6%
• Tumor 6%
• Immunohistochemistry 6%
• Tumor Progression 6%
• Binding Protein 6%
• Ovarian Cancer 6%
• Chromatin Immunoprecipitation (ChIP) 6%
• Opposite Effects 6%
• Over 80 6%
• Rescue Experiments 6%
• Biological Role 6%
• FIGO Stage 6%
• Novel Therapeutic Targets 6%
• Expression Activity 6%
• Colony Formation 6%
• Putative Drug Targets 6%
• ChIP Assay 6%
• Promoter Binding 6%
• Ovarian Cancer Progression 6%
• Sphere Formation Assay 6%
• Trait-mediated Effects 6%

Medicine and Dentistry

• Cancer Growth 100%
• Telomerase Reverse Transcriptase 100%
• Krukenberg Tumor 100%
• Promoter Region 25%
• Carcinogenesis 16%
• Cancer Cell 16%
• Xenograft 16%
• Luciferase Assay 16%
• Immunohistochemistry 8%
• Tumor Progression 8%
• Protein Binding 8%
• Ovarian Cancer 8%
• Cancer Tissue 8%
• Chromatin Immunoprecipitation 8%
• Colony Formation 8%
• Tumor 8%

Biochemistry, Genetics and Molecular Biology

• Telomerase Reverse Transcriptase 100%
• Cancer Cell 36%
• Promoter Region 27%
• Cell Growth 18%
• Carcinogenesis 18%
• Luciferase 18%
• Binding Protein 9%
• Tumor Progression 9%
• Chromatin Immunoprecipitation 9%
• Colony Formation 9%